An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control

被引:214
作者
Gualberto, A
Aldape, K
Kozakiewicz, K
机构
[1] Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA
[2] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA
关键词
D O I
10.1073/pnas.95.9.5166
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although it is well-established that p53 functions as a tumor suppresses gene, certain mutations exhibit gain-of-function activities that increase oncogenic transformation. We have found a common class of p53 missense mutations that exhibits a dominant, gain-of-function activity that generates genomic instability. Fibroblasts frown Li-Fraumeni syndrome heterozygotes with such mutations generate polyploid cells when exposed to spindle depolymerizing agents. Expression of such mutant alleles in normal fibroblasts yields the same phenotype. This class of dominant, gain-of-function p53 mutation (p53(RSC), relaxed spindle checkpoint allele) does not require the transcriptional activation function of p53 for this behavior. Thus p53 mutations can contribute to progression of a cancer cell not only by absence of p53 humor suppressor activity but also by the presence of an activity that promotes genetic instability.
引用
收藏
页码:5166 / 5171
页数:6
相关论文
共 53 条
  • [41] HOW LOOPS, BETA-SHEETS, AND ALPHA-HELICES HELP US TO UNDERSTAND P53
    PRIVES, C
    [J]. CELL, 1994, 78 (04) : 543 - 546
  • [42] The spindle assembly checkpoint
    Rudner, AD
    Murray, AW
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (06) : 773 - 780
  • [43] SHACKNEY SE, 1989, CANCER RES, V49, P3344
  • [44] SHAULSKY G, 1991, CANCER RES, V51, P5232
  • [45] SRIVASTAVA S, 1993, ONCOGENE, V8, P2449
  • [46] CDC5 and CKII control adaptation to the yeast DNA damage checkpoint
    Toczyski, DP
    Galgoczy, DJ
    Hartwell, LH
    [J]. CELL, 1997, 90 (06) : 1097 - 1106
  • [47] Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
    Waldman, T
    Lengauer, C
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1996, 381 (6584) : 713 - 716
  • [48] WEINERT TA, 1993, GENETICS, V134, P63
  • [49] DIFFERENTIAL DISRUPTION OF GENOMIC INTEGRITY AND CELL-CYCLE REGULATION IN NORMAL HUMAN FIBROBLASTS BY THE HPV ONCOPROTEINS
    WHITE, AE
    LIVANOS, EM
    TLSTY, TD
    [J]. GENES & DEVELOPMENT, 1994, 8 (06) : 666 - 677
  • [50] THE 19-KILODALTON ADENOVIRUS E1B TRANSFORMING PROTEIN INHIBITS PROGRAMMED CELL-DEATH AND PREVENTS CYTOLYSIS BY TUMOR-NECROSIS-FACTOR-ALPHA
    WHITE, E
    SABBATINI, P
    DEBBAS, M
    WOLD, WSM
    KUSHER, DI
    GOODING, LR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) : 2570 - 2580